AbCellera Biologics Inc.
Disclosed SEC business address
150 W 4TH AVENUE, VANCOUVER, A1, V5Y 1G6
AbCellera Biologics Inc. (ticker ABCL, CIK 0001703057) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: British Columbia, Canada. Every item is grounded on the cited public source — no figures are fabricated.
You've reached this month's free company deep views
The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.
Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-19T08:39:26.912278+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:08.911974+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:12.880036+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:19:19.372416+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.